BusinessWeek Logo
MedImmune

Getty Images

MedImmune

Description: Biotechnology company, maker of products including the flu virus FluMist and treatments for chemotherapy side effects
Size of deal: $15.7 billion
Date deal announced: Apr. 22, 2007
Buyer: AstraZeneca (AZN)
Buyer location: London